Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase 1/2 2Phase 4 1Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 2Lymphoid 1

Conditions

Multiple Myeloma 2Neoplasms, Plasma Cell 1Lymphoma, Follicular 1Disease 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Completed × Transplantation, Autologous × Clear all
NCT00950768 2009-08-03

Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

Azienda Ospedaliera San Giovanni Battista

Phase 3 Completed
298 enrolled
Plasma cell

Disease, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00560053 2008-11-27

Pethema Multiple Myeloma 2000

PETHEMA Foundation

Phase 3 Completed
500 enrolled
Plasma cell

Multiple Myeloma

NCT00140569 2005-09-01

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Lymphoma Study Association

Phase 3 Completed
400 enrolled
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡